Actinium Pharmaceuticals, Inc. (ATNM)
1.455
+0.04
(+2.46%)
USD |
NYAM |
Dec 11, 16:00
1.455
0.00 (0.00%)
After-Hours: 20:00
Actinium Pharmaceuticals Free Cash Flow: -25.04M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Arcus Biosciences, Inc. | -464.00M |
| Apyx Medical Corp. | -9.503M |
| AbbVie, Inc. | 19.68B |
| Karyopharm Therapeutics, Inc. | -89.30M |
| NovaBay Pharmaceuticals, Inc. | -7.012M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -6.325M |
| Cash from Financing (Quarterly) | -0.209M |
| Free Cash Flow Per Share (Quarterly) | -0.2028 |
| Free Cash Flow to Equity (Quarterly) | -6.178M |
| Free Cash Flow to Firm (Quarterly) | -6.325M |
| Free Cash Flow Yield | -55.17% |